A challenge within the field of bioconjugation
is developing probes
to uncover novel information on proteins and other biomolecules. Intracellular
delivery of these probes offers the promise of giving relevant context
to this information, and these probes can serve as hypothesis-generating
tools within complex systems. Leveraging the utility of triazabutadiene
chemistry, herein, we discuss the development of a probe that undergoes
reduction-mediated deprotection to rapidly deliver a benzene diazonium
ion (BDI) into cells. The intracellular BDI resulted in an increase
in global tyrosine phosphorylation levels. Seeing phosphatase dysregulation
as a potential source of this increase, a tyrosine phosphatase (PTP1B)
was tested and shown to be both inhibited and covalently modified
by the BDI. In addition to the expected azobenzene formation at tyrosine
side chains, key reactive histidine residues were also modified.